Modulation of the JNK pathway in liver affects insulin resistance status
- PMID: 15331609
- DOI: 10.1074/jbc.M406963200
Modulation of the JNK pathway in liver affects insulin resistance status
Abstract
The c-Jun N-terminal kinase (JNK) pathway is known to be activated under diabetic conditions and to possibly be involved in the progression of insulin resistance. In this study, we examined the effects of modulation of the JNK pathway in liver on insulin resistance and glucose tolerance. Overexpression of dominant-negative type JNK in the liver of obese diabetic mice dramatically improved insulin resistance and markedly decreased blood glucose levels. Conversely, expression of wild type JNK in the liver of normal mice decreased insulin sensitivity. The phosphorylation state of crucial molecules for insulin signaling was altered upon modification of the JNK pathway. Furthermore, suppression of the JNK pathway resulted in a dramatic decrease in the expression levels of the key gluconeogenic enzymes, and endogenous hepatic glucose production was also greatly reduced. Similar effects were observed in high fat, high sucrose diet-induced diabetic mice. Taken together, these findings suggest that suppression of the JNK pathway in liver exerts greatly beneficial effects on insulin resistance status and glucose tolerance in both genetic and dietary models of diabetes.
Similar articles
-
Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance.J Endocrinol. 2008 May;197(2):287-96. doi: 10.1677/JOE-08-0061. J Endocrinol. 2008. PMID: 18434358
-
Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes.Mol Endocrinol. 2004 Aug;18(8):2024-34. doi: 10.1210/me.2003-0383. Epub 2004 May 13. Mol Endocrinol. 2004. PMID: 15143153
-
Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling.Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E307-15. doi: 10.1152/ajpendo.00534.2007. Epub 2007 Nov 20. Am J Physiol Endocrinol Metab. 2008. PMID: 18029441
-
c-Jun N-terminal kinase pathways in diabetes.Int J Biochem Cell Biol. 2008;40(12):2702-6. doi: 10.1016/j.biocel.2008.06.012. Epub 2008 Jul 17. Int J Biochem Cell Biol. 2008. PMID: 18678273 Review.
-
Emerging role of JNK in insulin resistance.Curr Diabetes Rev. 2013 Sep;9(5):422-8. doi: 10.2174/15733998113099990074. Curr Diabetes Rev. 2013. PMID: 23865415 Review.
Cited by
-
Inflammation, stress, and diabetes.J Clin Invest. 2005 May;115(5):1111-9. doi: 10.1172/JCI25102. J Clin Invest. 2005. PMID: 15864338 Free PMC article. Review.
-
PGC-1α in hepatic UPR during high-fat high-fructose diet and exercise training in mice.Physiol Rep. 2018 Aug;6(15):e13819. doi: 10.14814/phy2.13819. Physiol Rep. 2018. PMID: 30105901 Free PMC article.
-
Role of reactive oxygen species in injury-induced insulin resistance.Mol Endocrinol. 2011 Mar;25(3):492-502. doi: 10.1210/me.2010-0224. Epub 2011 Jan 14. Mol Endocrinol. 2011. PMID: 21239612 Free PMC article.
-
Cudrania tricuspidata water extract improved obesity-induced hepatic insulin resistance in db/db mice by suppressing ER stress and inflammation.Food Nutr Res. 2015 Oct 26;59:29165. doi: 10.3402/fnr.v59.29165. eCollection 2015. Food Nutr Res. 2015. PMID: 26507490 Free PMC article.
-
Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways.Gastroenterology. 2013 Mar;144(3):636-649.e6. doi: 10.1053/j.gastro.2012.10.051. Epub 2012 Nov 6. Gastroenterology. 2013. PMID: 23142626 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous